Global Liquid Biopsy Technology Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Liquid Biopsy Technology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating tumor DNA or ctDNA) present in body fluids, primarily blood, to detect and monitor various diseases, especially cancer. Unlike traditional biopsies that involve invasive procedures to collect tissue samples, liquid biopsy offers a less invasive and potentially more convenient method for disease detection and monitoring.

The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.

This report is a detailed and comprehensive analysis for global Liquid Biopsy Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Liquid Biopsy Technology market size and forecasts, in consumption value ($ Million), 2020-2031

Global Liquid Biopsy Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Liquid Biopsy Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Liquid Biopsy Technology market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Liquid Biopsy Technology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Liquid Biopsy Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Exact Sciences, Guardant Health, Natera, Bio-Techne, LabCorp, Endress+Hauser, MDxHealth, MutantDx, Thermo Fisher Scientific, Norgen Biotek, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Liquid Biopsy Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
CTCs
ctDNA
Exosomes

Market segment by Application
Blood Sample
Urine Sample
Other Bio Fluids

Market segment by players, this report covers
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Liquid Biopsy Technology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Liquid Biopsy Technology, with revenue, gross margin, and global market share of Liquid Biopsy Technology from 2020 to 2025.

Chapter 3, the Liquid Biopsy Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Liquid Biopsy Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy Technology.

Chapter 13, to describe Liquid Biopsy Technology research findings and conclusion.